baber/WOPTO huggingface dataset:
Patent ES-525036-A0 (ES)
IPC: B22D11/12
Filed: 1983-08-19
Abstract: 1. A device for the longitudinal division of slabs in a continuous casting plant, comprising at least one torch cutter device which is disposed above a roller table (2) receiving the slab (1) for division and which comprises a torch car (10) having a torch (24) and mobile on rails in the direction of transport of the slab (1), and comprising means for producing a relative alignment between the slab (1) and a torch track (14), in which the torch (24) is held slidably by a torch slide (21) on an arm (24) disposed perpendicularly to the direction of transport of the slab (1) and is guided relatively to the slab (1) by two mobile alignment cars (35) connected to the torch slide (21), characterized in that the torch track (14) is fixed on the two mobile alignment cars (35) for the purposes of adjustment of said track.
Patent ES-525131-A0 (ES)
IPC: C23C22/73
Filed: 1983-08-24
Abstract: Metal surfaces are phosphated by acidic aqueous phosphate solutions containing:
 (a) from 0.1 to 2 g/l of zinc ion;
 (b) from 5 to 50 g/l of phosphate ion;
 (c) from 0.2 to 4 g/l of manganese ion;
 (d) at least 0.05 g/1 of fluoride ion; and
 (e) a phosphating accelerator. 
<??>The phosphated metal surface is suitable for electro-coating.
Patent ES-525824-A0 (ES)
IPC: C07C59/90
Filed: 1983-09-22
Abstract: Compounds of the formulae: <CHEM> and their pharmaceutically acceptable (including acid-addition) salts, which are novel, are antagonists of leukotrienes of C4, D4 and E4, the slow reacting substance of anaphylaxis. They can be made into pharmaceutical compositions by incorporating them in a pharmaceutical carrier. In the formulae, each R is H, OH, SH, C1-6 alkyl, C2-6 alkenyl, CF3, C1-6 alkoxy, C1-6 alkythio, phenyl, phenyl having C1-3 alkyl or halogen substitution, phen (C2-4 alkyl), halogen, amino, N(R4)2, COOR4 or CH2OR4 where R4 is H or C1-6 alkyl, formyl, CN, CF3S or NO2; each R<1> is R4; OR4; COOR4; N(R4)2; SR4; CH2OR4 or CHO; or together R min  and R min  are O, CH2 or <CHEM>  Y is oxyge, sulfur, sulfoxide, sulfone,    @ = NR11,  = NR12, = N - CO - R13 or - N - CN, where R11 is C1-4 alkyl, R12 is H or C1-4 alkyl and R13 is C1-4 alkyl or C1-4 alkoxy;  Y min  is Y, -CH2- or    - @ -;  each R1 is hydrogen or C1-3 alkyl;  each m is an integer from 0 to 6; <CHEM>  where Z is O, S, CH2, H and OH, C1-4 alkenyl, or = N - R14, where R14 is OH, CN, COOH, halogen, formyl, C1-6 acyl, C1-6 alkyl, C1-6 alkoxy, C1-6 halogenated alkyl, phenyl, or phenyl having C1-3 alkyl or C1-3 alkoxy substitution; each R6 is H or C1-4 alkyl; each R7 is H, OH or C1-4 alkyl; each R8 is H or C1-4 alkyl and is absent when the two indicated carbons are triply bonded; R5 is COOR4; CH2OH; CHO; tetrazole; NHSO2R14; CONHSO2R14 hydroxymethylketone; CN; CON(R7)2; a monocyclic or bicyclic heterocyclic ring containing an acidic hydroxyl group; or COOR15 where R15 is: <CHEM> where each s is  independently 0-3, R6 is as defined above and R16 is (A) a monocyclic or bicyclic heterocyclic radical containing from 3 to 12 nuclear carbon atoms and 1 or 2 N heteroatoms or one N and one S heteroatom, each ring in the heterocyclic radical being formed of 5 or 6 atoms, or (B) W-R17 where W is O, S or NH and R17 contains up to 21 carbon atoms and is (1) a hydrocarbon radical or (2) an acyl radical or an organic acylic or monocyclic carboxylic acid containing not more than 1 heteroatom in the ring;  each of r and q is 0-20 but r + q does not exceed 20; and  p is 0 or 1;  R3 is C1-6 alkyl or C3-6 alkenyl; R9 is C1-6 alkyl, C1-6 alkoxy or (CH2)rR5, where r and R5 are as defined above; and R10 is H, C1-6 alkyl; R4CO- or R4OCH2, where R4 is as defined above.   The compounds are prepared by condensing together two compounds having appropriately substituted benzene rimgs, one of which contains a halogen atom in the chain containing Y and Y min , which removes a hydrogen atom from the ring of the other compound.
Patent ES-528211-A0 (ES)
IPC: A61K38/095
Filed: 1983-12-20
Abstract: Novel vasotocin derivatives having an inhibitory effect on uterine contractions, pharmaceutical compositions containing these derivatives, and the use thereof in the therapeutical treat- nent of excessive muscle contractions in the uterus are described. The derivatives differ from vasotocin in that the structure of the original hormone has been modified at positions 1, 2 and, optionally, 4 and/or 8. The vasotocin derivatives thus iave the formulawhereinMpa is a 3-mercaptopropionyl residue (-S-CH<sub>2</sub>- CH<sub>2</sub>-CO-);A is the peptide residue of L- or D-tyrosine-O-ethyl ether (in other words, 4-ethoxy-L or D-phenyl alanine, i.e. L-or D-Tyr(Et)), or of a hydrophopic D-amino acid, such as D-tyrosine(D-Tyr) or D-tryptophane(D-Trp);Ile is the peptide residue of isoleucine;B is the peptide residue of glutamine (Gin), treonine (Thr) or valine (Val);Asn is the peptide residue of asparagin;Cys is the peptide residue of cysteine;Pro is the peptide residue of proline;C is the peptide residue of L- or D-arginine (Arg), ornithine (Orn) or citrullin (Cit); andGly-NH<sub>2</sub> is the peptide residue of glycine amide.
Patent ES-531054-A0 (ES)
IPC: C08G59/50
Filed: 1984-03-28
Abstract: The object of the invention is a process for the production of flat varnishes based on powder coatings of 1,2-epoxy compounds with at least one 1,2-epoxy group in the molecule and a lower melting point of >40 DEG  C., salts of aromatic carboxylic acids with 3 and more carboxyl groups and imidazolines as curing agents, as well as the usual additives and the application of the powdered varnish upon the objects to be varnished and heating of these objects to temperatures of 160 DEG -240 DEG  C., whereby the salt of 2-phenyl-methyl- DELTA 2-imidazoline and trimellitic acid is substituted up to 60 mole % by a salt of 2-phenyl- DELTA 2-imidazoline and trimellitic acid.
Patent ES-538015-A0 (ES)
IPC: B65C9/22
Filed: 1984-11-27
Abstract: Apparatus and methods are disclosed for a high speed par duction line in which containers (8) are wrapped with plastics labels (10) each having an outer surface and an un nerside which is next to the container (10) and comprising a fi nt solid polymer layer (20) or a foam polymer layer (60), incl nding means (23, 38, 45) for moving a leading edge (61) of a abel (10) to the periphery (12) of a rotating vacuum drum (5), means for applying a solvent, such as methylene chic ide when the polymer is polystyrene, to the underside of the layer to form finite areas (65) on the leading label edge (61) nd a finite area (66) on the trailing edge (68). The finite areas 65, 66) have therein a rapidly soldifying tacky solution of the bolymer in the solvent, the tacky viscous solutions rapidl solidifying to form an adhesive bond. The solvent- applie label (10) is quickly moved to a label wrapping statior vhere it is wrapped around a container (8), the finite areas (66) on the leading edge (61) tacking the label (10) to the cor t iner (8), and the finite area (66) on the trailing edge (68) fo ning a cohesive bond on the seam formed by the overlap: ed label ends.
Patent ES-555181-A0 (ES)
IPC: G07F5/08
Filed: 1986-05-21
Abstract: This invention relates to coin selector mechanisms having in a consecutive arrangement three protection zones, two of them being optical and one of them being and electromagnetic zone intermediate the two optical zones, the optical zones taking the form of phototransistor type sensors while the electromagnetic zone, which is preferably the central zone, is embodied by at least one and preferably two windings which are interconnected and positioned opposite one another on either side of the coin path so that the fields produced by the coils intercept the coin path, the coils being connected to an oscilattor having two outputs, one output being connected to a microprocessor and the other output being connected to a rectifier connected to an analog-to-digital converter which outputs to the microprocessor.
Patent ES-557733-A0 (ES)
IPC: C07K5/06
Filed: 1987-09-16
Abstract: The invention discloses a series of difluoroketone mono. di- and tri-peptide derivatives of the formula la, Ib and Ic:-and salts thereof where appropriate, and wherein the radicals are defined hereafter in the specification. The derivatives are useful in inhibiting the action of human leukocyte elastase. There are also disclosed methods and intermediates for the manufacture of, and pharmaceutical compositions comprising, the said derivatives.
Patent FI-870565-A0 (FI)
Inventor: BONNET EVELYNE
IPC: C07D209/66
Filed: 1987-02-11
Abstract: The invention relates to the preparation of halogenated imides derived from hydrazine and halogenated dicarboxylic acid anhydride and which can be used as flameproofing agents for plastics. The condensation of hydrazine and halogenated dicarboxylic acid anhydride is carried out in an aqueous medium, at a temperature ranging from 40 DEG  to 225 DEG  C., with a molar ratio of anhydride/hydrazine substantially equal to 2.
Patent FI-870805-A0 (FI)
Inventor: SUTHERLAND PAUL H
IPC: D21F7/08
Filed: 1987-02-25
Abstract: A papermaker's multilayer fabric having at least top and bottom layers of machine direction yarns which are interwoven with cross machine direction yarns systems to establish a first interwoven fabric layer which is bound to a bottom layer fabric with the two being united by interweaving cross machine direction yarns from the bottom fabric layer in the upper fabric layer. The effective pressing surface area of the first fabric layer being equal to or greater than (x + 1) + (0.5y). Wherein (x + 1) defines the contribution of the upper fabric layer to the effective pressing surface area and the contribution of the binding yarn is defined by the y factor of the equation. Accordingly, the total effective pressing area is defined by the contributions of the upper ply and the binding yarns.
Patent FI-901919-A0 (FI)
Inventor: KAJIKAWA AKIRA
IPC: A01N25/12
Filed: 1990-04-17
Abstract: This invention relates to dry, water soluble, pesticidally acceptable particulate compositions, to a method of use thereof for killing or controlling pests including weeds and to a process for preparing such compositions. This invention also relates to dry, water soluble and/or water dispersible, pesticidally acceptable particulate herbicidal compositions ccntaining one or more herbicides, a herbicidal method of use thereof and to a process for preparing such compositions. The dissolution or dispersible rates of particulate pesticidal compositions in water are enhanced by the presence of a small but effective amount of an organosilicone block copolymer wetting agent or a fluorocarbon wetting agent.
Patent FI-915443-A0 (FI)
Inventor: HOUGHTON MICHAEL
IPC: C12Q1/68
Filed: 1991-11-18
Abstract: A new virus, Hepatitis C virus (HCV), which has proven to be the major etiologic agent of blood-borne NANBH, was discovered by Applicant. Reagents for isolating, amplifying, and detecting HCV polynucleotides are provided. These reagents are oligomers comprised of polynucleotide sequences which are capable of forming hybrid structures with HCV target polynucleotide sequences.
Patent FI-922380-A0 (FI)
Inventor: RAMAGE PAUL IAN NICOLAS
IPC: C07K14/00
Filed: 1992-05-25
Abstract: Following are described. (A) purified prepn. of an anti-CDw52 antibody which exhibits on size exclusion chromatography a single peak under non-reducing conditions and 2 major peaks under reducing conditions; esp. the prepn. exhibits on conventional SDS polyacrylamide gel electrophoresis, one main band using a non-reduced sample and two main bands using a reduced sample; (B) purified prepn. of an anti-CDw52 antibody having a specific activity greater than 0.8 KU/mg; (C) purified prepn. of an anti-CDw52 antibody, free from host cell contaminants and/or aggregates; (D) purifying an anti-CDw52 antibody comprising (a) applying an aqs. soln. of the antibody to a Protein A column so as to absorb the antibody and eluting the antibody with an acid soln., (b) applying the acidic eluate to an ion-exchange column of charged particles to absorb the antibody and then eluting the antibody with an aqs. soln. of counter-charged ions and (c) applying the aqs. eluate to a size exclusion column of porous particles to retain non-antibody mols. in the porous particles and to obtain the desired antibody in selected fractions produced from the column. Pref. the Protein A column is Protein A Sepharose and the antibody is eluted with citric acid.
Patent FI-924337-A0 (FI)
Inventor: SMITH STEVEN DARYL
IPC: A61K6/00
Filed: 1992-09-28
Abstract: Amine-substituted vinyl polymer is used to improve the performance properties of various adhesives. Adhesives such as the alkyl vinyl ether/maleic acids and various other polymeric adhesives exhibit improved holding properties when combined with the amine-subsituted polymer, especially in the presence of moisture. Improved bioadhesives, e.g., denture adhesives, are provided.
Patent FI-940610-A0 (FI)
Inventor: PELENC VINCENT PASCAL
IPC: C09K23/56
Filed: 1994-02-10
Abstract: The present invention relates to a method for the enzymatic production of $g(a)-glucosides, characterized by contacting at least one alcohol whose only functional group or groups is/are a hydroxyl group or groups, with starch, maltodextrines or maltose, in the presence of a purified enzymatic preparation having an $g(a)-transglucosylation activity. The invention relates also to an enzymatic method for the esterification of the $g(a)-glucosides thus obtained.
Patent FI-943752-A0 (FI)
Inventor: SWEENEY PAUL A
IPC: F25J3/04
Filed: 1994-08-15
Abstract: A process and apparatus for producing a high purity nitrogen vapour product from the rectification of air within high and low pressure columns 24 and 26 respectively, operatively associated with one another by a condenser-reboiler 28. The high pressure column incorporates a sufficient number of theoretical stages to produce a high purity nitrogen vapour which downstream of being condensed in the condenser-reboiler 28, serves partially to condense in a heat exchanger 42 a lower purity nitrogen fraction produced at the top the low pressure column 26. In such service, the condensed, high purity nitrogen vapour is at least partially vaporized and utilized as a product stream. Since there is intermixing with the high purity nitrogen produced within the high pressure column 24 and the lower purity nitrogen vapour produced in the low pressure column 26, the low pressure column 26 can incorporate fewer theoretical stages and therefore can be built at less expense than similar air separation plants of the prior art. <IMAGE>
Patent FI-943874-A0 (FI)
Inventor: HYYRYNEN ALTTI
IPC: H04Q1/20
Filed: 1994-08-23
Abstract: PCT No. PCT/FI95/00444 Sec. 371 Date Feb. 21, 1997 Sec. 102(e) Date Feb. 21, 1997 PCT Filed Aug. 22, 1995 PCT Pub. No. WO96/06474 PCT Pub. Date Feb. 29, 1996In a method and system for recovering a faulty unit, a predetermined number of recovery periods, and the maximum number of times a recovery act is carried out during a recovery period, are defined. A faulty unit is taken out of operation, recovered (i.e. subjected to a procedure designed for remediating the fault, if possible), and brought back into operation if tests indicate that the unit is in condition (i.e., is not faulty). The recovered unit is monitored for the time of succeeding recovery periods and is re-recovered, if necessary, provided that the number of the recovery acts carried out during each recovery period does not exceed the maximum number predetermined for the respective period. As a result, bouncing of the unit back and forth in an uncontrolled manner, if the fault is of such a type that the recovery system cannot detect it on the basis of the tests carried out, is reduced and eventually curtailed.
Patent FI-951656-A0 (FI)
Inventor: KEURENTJES JOHANNES THEODORUS
IPC: B01D61/36
Filed: 1995-04-06
Abstract: Proposed is a process for separating enantiomers from a racemic mixture by countercurrent extraction using at least two liquids of mutually differing chiralities, said liquids being wholly miscible and separated from each other by a phase with which they are immiscible. The separating, immiscible phase may be incorporated into a solid carrier which may be porous or not and preferably is in the form of a hollow fibre. The liquids of mutually differing chiralities may be chirally active as such or, alternatively, be obtained by the incorporation of a chiral adjuvant into at least one of the extracting liquids.
Patent FI-955180-A0 (FI)
Inventor: MONGELLI NICOLA
IPC: A61P31/12
Filed: 1995-10-30
Abstract: PCT No. PCT/EP95/00444 Sec. 371 Date Oct. 30, 1995 Sec. 102(e) Date Oct. 30, 1995 PCT Filed Feb. 8, 1995 PCT Pub. No. WO95/23806 PCT Pub. Date Sep. 8, 1995Subject of the present invention are new ureido derivatives of naphthalenephosphonic acids having the following formula (I)    <IMAGE>  (I)    <IMAGE>   wherein each of m and n, which are the same, is an integer of 1 to 4; each of p and q, which are the same, is an integer of 1 to 3; and each of the R groups, which are the same, is a free or esterified phosphonic acid group; and the pharmaceutically acceptable salts thereof.
Patent FI-961313-A0 (FI)
Inventor: MUSZYNSKI PETER
IPC: H04W36/12
Filed: 1996-03-21
Abstract: The cellular communications system includes CDMA and diversity combining with soft hand-off. The system has a number of mobile switching stations (MSC) connected to each other and the PSTN. These stations are connected via base stations (BS) to a mobile station (MS). An MS (30) is normally linked to the PSTN via a BS (24) an MSC (14). When the MS detects a valid pilot signal from another BS (22) it signals its MSC which establishes a diversity link (82,72,50) via another MSC (12). The mobile station combines the signals from multiple stations and provides soft hand-off.
Patent FI-961506-A0 (FI)
Inventor: BERIA ITALO
IPC: A61P31/12
Filed: 1996-04-03
Abstract: PCT No. PCT/EP95/02814 Sec. 371 Date Mar. 18, 1996 Sec. 102(e) Date Mar. 18, 1996 PCT Filed Jul. 18, 1995 PCT Pub. No. WO96/05196 PCT Pub. Date Feb. 22, 1996The present invention relates to compounds of formula (I)    <IMAGE>  (I)    <IMAGE>   The compounds of the invention are useful as antitumor or antiviral agents.
Patent FI-964565-A0 (FI)
Inventor: HENTON DANIEL R
IPC: A61K31/445
Filed: 1996-11-14
Abstract: The present invention is related to novel processes for preparing anhydrous and hydrated forms of piperidine derivatives, polymorphs and pseudomorphs thereof of the formulas   
which are useful as antihistamines, antiallergic agents and bronchodilators.
Patent FI-964832-A0 (FI)
Inventor: OPLENSKDAL OLAV
IPC: A47C1/036
Filed: 1996-12-03
Abstract: A recline chair (1) has a neck support (3) and an adjustable back (2) whose shape can altered by an adjusting mechanism (12,15). A pronounced support is provided for the chair user's lower back when the chair back is in an erected sitting position. The adjusting mechanism render a gradually decreasing support of the user's lower back when the chair back is lowered rearwardly towards a lying position. The lumbar region support (6) cooperates with a neck support regulating system to return the neck support to a normal position when the chair back is in extreme upper or lower position.
Patent FI-970867-A0 (FI)
Inventor: ROSER BRUCE JOSEPH
IPC: A61K9/00
Filed: 1997-02-28
Abstract: A device for the topical subcutaneous, intradermal or transdermal delivery of a therapeutic agent, wherein the device includes a composition comprises the therapeutic agent and a glass-forming polyol and/or a hydrophobic derivatised carbohydrate (HDC) having a carbohydrate backbone up to pentasaccharide in length, wherein more than one hydroxyl group of the carbohydrate is substituted with a less hydrophilic derivative thereof.
Patent FI-980571-A0 (FI)
Inventor: HAKALEHTO ELIAS
IPC: C12Q1/04
Filed: 1998-03-13
Abstract: A method for microbial detection in an early phase of the enrichment culture with the aid of extensive expression of certain antigens started by the microbes already before the logarithmic phase of the cell growth. The method can particularly be applied for the detection of Salmonella and other enteric bacteria.
Patent FI-990789-A0 (FI)
Inventor: CAPROTTI RINALDO
IPC: C10L1/222
Filed: 1999-04-12
Abstract: Specific substituted aromatic amine salt compounds are useful as lubricity additives for middle distillate fuel oils.
Patent IL-70698-A0 (IL)
Title: Indole derivatives
IPC: A61P25/26
Filed: 1984-01-16
Abstract: 1. Indole derivatives of the general formula I  see diagramm : EP0114603,P10,F1  in which Ind is a 3-indolyl radical which can be substituted once or twice by alkyl, O-alkyl, S-alkyl, SO-alkyl, SO2 -alkyl, OH, F, CL, Br, CF3 and/or CN or by a methylenedioxy group, A is -(CH2 )n -, n is 3, 4 or 5, Ar is a hydroxyphenyl group and the two radicals L are each H or together are a C-C bond, and in which the alkyl groups each have 1-4 C atoms, and their physiologically acceptable acid addition salts.
Patent IL-72664-A0 (IL)
Title: Controlled release pharmaceutical compositions comprising cross-linked,porous polymers
IPC: C08L33/00
Filed: 1984-08-13
Abstract: A controlled-release, drug-delivery composition which comprises (A) a crosslinked copolymer, capable of swelling in ethanol to give a swollen copolymer containing at least 40% by weight of ethanol, and capable of swelling in water to give a swollen copolymer containing no more than 20% by weight of water, where the swelling ratio (% ethanol: % water) is 2:1 to 22:1, which comprises the copolymerization product of (a) 50 to 99% by weight of said copolymer of a water-insoluble monoolefinic monomer or (a) with 0 to 45% by weight of total monomers of a water-soluble monoolefinic monomer, with (b) 50 to 1% by weight, but not more than 20 mol % of a divinyl or polyvinyl crosslinking agent; and (B) an effective amount of a pharmaceutical medicament is useful for the controlled and prolonged release of drugs when taken orally.
Patent IL-90829-A0 (IL)
Title: Process and apparatus for preparation of finely grained lead azide
IPC: C06B35/00
Filed: 1989-06-30
Abstract: The invention provides a process for the preparation of finely grained lead azide, in which aqueous solutions of lead nitrate and sodium azide are stirred in a vessel at constant temperature, characterized in that in a first process step the aqueous solution of lead nitrate and a small amount of an aqueous solution of sodium citrate are poured into the vessel, in a second process step, the aqueous solution of sodium azide is dosed into the vessel over a period of time of 30 to 40 minutes, the aqueous solutions poured into the vessel are agitated at a peripheral stirring speed of between 0.2 m/sec and 1.0 m/sec., and the constant temperature is set to a value of 50 DEG  C. to 80 DEG  C.
Patent IL-91306-A0 (IL)
Title: Tissue plasminogen activator having zymogenic or fibrin specific properties
IPC: C12N15/58
Filed: 1989-08-14
Abstract: Tissue plasminogen activator (t-PA) zymogens and variants are prepared, including a fibrinolytically active variant of t-PA that has an amino acid alteration at a site within the protease domain of t-PA as compared with the corresponding wild-type t-PA, which alteration renders the variant zymogenic in the presence of plasmin-degraded fibrinogen, and/or fibrin (or plasma clot) specific, as compared to the corresponding wild-type t-PA. DNA sequences can be prepared that encode the zymogens and variants, as well as expression vectors incorporating the DNA sequences, and host cells transformed with the expression vectors. The zymogens and variants may be used in a pharmaceutical preparation to treat a vascular disease or condition or to prevent fibrin deposition or adhesion formation or reformation in mammals.